Outcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE

Affiliation auteurs!!!! Error affiliation !!!!
TitreOutcomes after transaortic transcatheter aortic valve implantation: long-term findings from the European ROUTE
Type de publicationJournal Article
Year of Publication2019
AuteursCocchieri R, Petzina R, Romano M, Jagielak D, Bonaros N, Aiello M, Lapeze J, Laine M, Chocron S, Muir D, Eichinger W, Thielmann M, Labrousse L, Rein KArne, Verhoye J-P, Gerosa G, Bapat V, Baumbach H, Sims H, Deutsch C, Bramlage P, Kurucova J, Thoenes M, Frank D
JournalEUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
Volume55
Pagination737-743
Date PublishedAPR
Type of ArticleArticle
ISSN1010-7940
Mots-clésBalloon-expandable, Follow-up, Mortality, transaortic, transcatheter aortic valve implantation
Résumé

{OBJECTIVES There is lack of data regarding the longer-term outcomes of patients undergoing transaortic (TAo) transcatheter aortic valve implantation (TAVI). We aimed to provide a contemporary snapshot of the types and frequencies of events in the year following TAo-TAVI. METHODS The Registry of the Utilization of the TAo-TAVI approach using the Edwards SAPIEN Valve (ROUTE) is a multicentre, European, prospective, observational registry of aortic stenosis patients undergoing TAo-TAVI. Patients were grouped according to the composite end point death, myocardial infarction, stroke/transient ischaemic attack, major vascular complications, life-threatening bleeding, acute kidney injury (AKI) and/or cardiovascular rehospitalization. RESULTS Two hundred and fifty-three patients with a mean age of 81.55.8years were included, of whom 89 (35.2%) patients met the composite end point (the event group) and 164 (64.8%) patients did not (the event-free group). New York Heart Association (NYHA) class III/IV (85.2% vs 71.8%
DOI10.1093/ejcts/ezy333